<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885546</url>
  </required_header>
  <id_info>
    <org_study_id>AGAFPGM02</org_study_id>
    <nct_id>NCT01885546</nct_id>
  </id_info>
  <brief_title>Accuracy Study for Enhanced Meter Feature</brief_title>
  <official_title>Accuracy Study for the Evaluation of Obtaining an Enhanced Meter Feature Using an AgaMatrix BGMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AgaMatrix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AgaMatrix, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This enhanced meter feature raises awareness among patients by providing additional&#xD;
      information regarding their glycemic control between Healthcare Professional visits. This&#xD;
      information may facilitate increased dialogue between patient and Healthcare Professionals&#xD;
      and can remind patients of the importance of glycemic control.&#xD;
&#xD;
      This study will evaluate a user's ability to obtain the enhanced meter feature.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>User's ability to obtain the enhanced meter feature</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Enhanced meter feature usability</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Home diabetes monitoring by patient using provided blood glucose monitoring system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AgaMatrix Blood Glucose Monitor</intervention_name>
    <arm_group_label>Enhanced meter feature usability</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type I or type II diabetes inclusive of the following populations:&#xD;
&#xD;
               1. Mixed insulin therapies&#xD;
&#xD;
               2. Basal insulin therapies&#xD;
&#xD;
               3. Continuous subcutaneous insulin infusion therapies&#xD;
&#xD;
               4. Multiple daily injection therapies&#xD;
&#xD;
               5. Non-insulin diabetic treatments (oral and injectable)&#xD;
&#xD;
               6. Life style (exercise and diet) diabetes management&#xD;
&#xD;
               7. New diagnosis of diabetes&#xD;
&#xD;
          -  Non diabetics&#xD;
&#xD;
          -  Able to speak and read English proficiently&#xD;
&#xD;
          -  Subjects must be willing to:&#xD;
&#xD;
               1. once a month, perform a 7 point blood glucose profile over the course of one day&#xD;
&#xD;
               2. perform fasting blood glucose tests every day&#xD;
&#xD;
               3. complete baseline and follow-up questionnaires&#xD;
&#xD;
               4. consent to baseline HbA1c assays&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Hct &lt;20 or &gt;60&#xD;
&#xD;
          -  Work for BGM competitor company (including, but not limited to Lifescan, Roche,&#xD;
             Abbott)&#xD;
&#xD;
          -  Homeless&#xD;
&#xD;
          -  Incarcerated&#xD;
&#xD;
          -  Mentally ill&#xD;
&#xD;
          -  Employees or students of the Research Site, including the Principal Investigator,&#xD;
             directly involved in the conduct of the protocol.&#xD;
&#xD;
          -  Has any condition that the Principal Investigator believes may interfere in the&#xD;
             subject's participation in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>MassResearch, LLC</name>
      <address>
        <city>Waltham</city>
        <state>Massachusetts</state>
        <zip>02453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>June 21, 2013</study_first_submitted>
  <study_first_submitted_qc>June 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2013</study_first_posted>
  <last_update_submitted>July 6, 2015</last_update_submitted>
  <last_update_submitted_qc>July 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>glucose</keyword>
  <keyword>glucometer</keyword>
  <pending_results>
    <submitted>July 10, 2018</submitted>
    <returned>August 6, 2018</returned>
    <submitted>August 13, 2018</submitted>
    <returned>September 12, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

